3-BROMO-2,5-DICHLOROPYRIDINE

We are 3-BROMO-2,5-DICHLOROPYRIDINE CAS:138006-41-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  3-BROMO-2,5-DICHLOROPYRIDINE
CAS.NO:138006-41-4
Synonyms:  3-BROMO-2,5-DICHLOROPYRIDINE
5-Brom-2,3-dichlorpyridin
 
Molecular Formula:C5H2BrCl2N
Molecular Weight:226.88600
 
Physical and Chemical Properties:
Density:1.848g/cm3
Boiling point:239ºC at 760mmHg
Melting point:98.3ºC
Flash point:98.3ºC
Index of Refraction:1.424-1.426
 
Specification:
Appearance:White powder
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Preserve in well-closed, light-resistant and airtight containers
Application: Pesticide intermediates, dye intermediates, flavor and fragrance intermediates, pharmaceutical intermediates

3-BROMO-2,5-DICHLOROPYRIDINE


Related News: We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.1017779-69-9 At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.2-(4-CHLOROPHENOXY)ANILINE At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.4-(Trifluoromethoxy)benzyl chloride Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.

Related Products
Product Name
trimethyl(1,2,4-triazol-1-yl)silane View Details
4-Fluoro-3-(trifluoromethyl)aniline View Details
5-Fluoropicolinic acid View Details
5-nitro-2,3-dihydro-1-benzofuran manufacturer Cyanoacetic acid manufacturer Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-carboxylate manufacturer 1,2,3,4,5-Pentafluorobenzene manufacturer 2,4-Dibromomesitylene manufacturer